Therefore, pathologically activated BRAF/MAPK signaling, possibly by BRAFV600E, initiates and promotes tumor development through transcriptionally elevating USP15 and protecting TBX3 from degradation, in addition to direct transcriptionally up-regulating TBX315. The gene discussed is BRAF; the disease is neoplasm.